We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Icad Inc (ICAD) USD0.01

Sell:$1.54 Buy:$1.60 Change: $0.15 (10.64%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Change: $0.15 (10.64%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Change: $0.15 (10.64%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company’s Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. It also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution.

Contact details

98 Spit Brook Rd Ste 100
United States
+1 (603) 8825200

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$37.16 million
Shares in issue:
26.35 million
Health Care Technology
United States
US dollar

Key personnel

  • Dana Brown
    Executive Chairman of the Board, President, Chief Executive Officer
  • Eric Lonnqvist
    Chief Financial Officer
  • Michelle Strong
    Chief Operating Officer
  • Jonathan Go
    Chief Technology Officer
  • Vasu Avadhanula
    Chief Product Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.